DexCom, Inc. vs Samsara Inc — how do they compare? DexCom, Inc. trades at $89.53 (market cap $33.08B), while Samsara Inc trades at $39.79 (market cap $23.23B). The key difference: DexCom, Inc. is the larger of the two by market cap, and DexCom, Inc. is trading nearer its 52-week high, Samsara Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | IOT | |
|---|---|---|
Market Cap | $33.08B | $23.23B |
Sector | Health | Technology |
52-Week High | $89.53 | $45.22 |
52-Week Low | $54.84 | $24.25 |
Enterprise Value | $32.53B | $22.49B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Samsara (IOT) trades at $40.88, up 6.96% in the last session, with a bullish technical signal from moving averages. The company reported revenue of $1.25B in 2025 but a net loss of $154.91M, though it has beaten EPS estimates for three consecutive quarters. Analyst sentiment is strongly positive, with 14 of 18 analysts rating it a Buy and a consensus price target of $44.50. Recent news highlights institutional buying and the company's focus on AI-driven growth.
The outlook is optimistic due to strong analyst support and consistent earnings beats, but risks include high valuation multiples and ongoing profitability challenges. Investors should weigh the growth potential in AI and connected operations against the current negative net income and elevated P/E ratio of 398.6.
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →